News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Kevin Kalinsky/winshipcancer.emory.edu
Jan 19, 2025, 07:17

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al., titled “Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial“ published on Journal of Clinical Oncology.

Authors: Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L. Graff, Kyong Hwa Park, Rinath Jeselsohn, Umut Demirci, Miguel Martin, Rachel M. Layman, Sara A. Hurvitz, Sarah Sammons, Peter A. Kaufman, Montserrat Muñoz, Jiun-I Lai, Holly Knoderer, Cynthia Sandoval, Aarti R. Chawla, Bastien Nguyen, Yanhong Zhou, Elizabeth Ravenberg, Lacey M. Litchfield, Lillian Smyth, Seth A. Wander.

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

“New at Journal of Clinical Oncology. Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial.“

Aarti R. Chawla Abemaciclib Bastien Nguyen Breast Cancer cancer Cynthia Sandoval Dana-Farber’s Breast Oncology Center Elizabeth Ravenberg Erika Hamilton Fulvestrant Giampaolo Bianchini Holly Knoderer Jiun-I Lai Journal of Clinical Oncology Kevin Kalinsky Kyong Hwa Park Lacey M. Litchfield Lillian Smyth Miguel Martin Montserrat Muñoz OncoDaily Oncology Peter A Kaufman postMONARCH Trial Rachel M. Layman Rinath Jeselsohn Sara A. Hurvitz Sarah Sammons Seth A Wander Stephanie L. Graff Umut Demirci Yanhong Zhou
Special Coverage
Science
Jan 19, 2025, 07:17
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Science
Jan 19, 2025, 07:02
Erman Akkus: Understanding the BRAF pathway
Science
Jan 19, 2025, 06:59
Paolo Tarantino: A new ADC is now available to treat the most common subtype of breast cancer
Science
Jan 19, 2025, 06:56
Pashtoon Kasi: One more option for our patients with Colorectal Cancer
Dialogues
Jan 19, 2025, 06:50
ctDNA for Colorectal Cancer - Early and Metastatic Settings
Dialogues
Jan 19, 2025, 06:47
Beyond the Cancer Diagnosis: Interview with Sami Mansfield, Hosted by Adrian Pogacian
Insight
Jan 19, 2025, 05:52
Proffered Paper Oral Presentations session - BGICC
Blog
Jan 19, 2025, 05:49
Estela Rodriguez: New podcast on ASCO Updated Guidelines on the management of pleural mesothelioma
Blog
Jan 19, 2025, 05:47
Jonathan Spicer: An outstanding talk by Cecilia Pompili on early-stage lung cancer at ELIXR24
Blog
Jan 19, 2025, 05:45
Margaret Foti: The medical research community is fortunate to have had Dr. Bertagnolli at the helm of the NIH
Blog
Jan 19, 2025, 05:34
New Bench to Bedside Chats from Project Catalyst’s initiative - FDA Oncology
Blog
Jan 19, 2025, 05:31
Michael White on what makes MD Anderson Cancer Center special